Insider Trading › OTIC › Insiders
OTIC
OTIC·Insider activity
—
No end-of-day price on record
OTIC
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
OTICS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of OTIC were filed in the last 180 days. Newest filing Nov 29, 2022 (3 years ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by OTIC insiders · Form 4 · last two years
No open-market insider buys or sells in the last two years.
On Record
$0Purchases · 180 days
$0Sales · 180 days
83Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of OTIC common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
83 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| CAPPS VICKIE LDirector | Sale | −42.2K | $0.10 | $4K | 3,400direct | Nov 28, 2022 | Nov 29, 2022 | Form 4 ↗ |
| Weber David AllenPresident & CEO · Director | Sale | −11.2K | $2.41 | $27K | 377.5Kdirect | Mar 28, 2022 | Mar 29, 2022 | Form 4 ↗ |
| Savel Robert Michael IIChief Technical Officer | Sale | −3,325 | $2.41 | $8K | 145.7Kdirect | Mar 28, 2022 | Mar 29, 2022 | Form 4 ↗ |
| Foster Alan CharlesChief Scientific Officer | Sale | −2,559 | $2.41 | $6K | 177.0Kdirect | Mar 28, 2022 | Mar 29, 2022 | Form 4 ↗ |
| Cayer Paul ECh. Financial & Business Offcr | Sale | −5,624 | $2.41 | $14K | 223.8Kdirect | Mar 28, 2022 | Mar 29, 2022 | Form 4 ↗ |
| Weber David AllenPresident & CEO · Director | Sale | −8,026 | $2.39 | $19K | 388.7Kdirect | Mar 25, 2022 | Mar 29, 2022 | Form 4 ↗ |
| Savel Robert Michael IIChief Technical Officer | Sale | −2,374 | $2.39 | $6K | 149.1Kdirect | Mar 25, 2022 | Mar 29, 2022 | Form 4 ↗ |
| Foster Alan CharlesChief Scientific Officer | Sale | −1,827 | $2.39 | $4K | 179.6Kdirect | Mar 25, 2022 | Mar 29, 2022 | Form 4 ↗ |
| Cayer Paul ECh. Financial & Business Offcr | Sale | −4,015 | $2.39 | $10K | 229.4Kdirect | Mar 25, 2022 | Mar 29, 2022 | Form 4 ↗ |
| Lichter JayDirector | Sale | −113.9K | $2.70 | $308K | 0indirect | Mar 3, 2021 | Mar 3, 2021 | Form 4 ↗ |
| Lichter JayDirector | Sale | −207.2K | $2.70 | $560K | 0indirect | Mar 3, 2021 | Mar 3, 2021 | Form 4 ↗ |
| Lichter JayDirector | Sale | −138.2K | $2.90 | $401K | 113.9Kindirect | Mar 2, 2021 | Mar 2, 2021 | Form 4 ↗ |
| Lichter JayDirector | Sale | −251.4K | $2.90 | $729K | 207.2Kindirect | Mar 2, 2021 | Mar 2, 2021 | Form 4 ↗ |
| Lichter JayDirector | Sale | −61.6K | $2.86 | $176K | 252.1Kindirect | Mar 1, 2021 | Mar 2, 2021 | Form 4 ↗ |
| Lichter JayDirector | Sale | −112.1K | $2.86 | $321K | 458.6Kindirect | Mar 1, 2021 | Mar 2, 2021 | Form 4 ↗ |
| Lichter JayDirector | Sale | −117.3K | $2.83 | $332K | 313.8Kindirect | Feb 26, 2021 | Mar 2, 2021 | Form 4 ↗ |
| Lichter JayDirector | Sale | −213.3K | $2.83 | $604K | 570.7Kindirect | Feb 26, 2021 | Mar 2, 2021 | Form 4 ↗ |
| Lichter JayDirector | Sale | −110.4K | $2.95 | $326K | 431.0Kindirect | Feb 25, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Lichter JayDirector | Sale | −200.7K | $2.95 | $592K | 784.0Kindirect | Feb 25, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Lichter JayDirector | Sale | −178.5K | $2.98 | $532K | 541.4Kindirect | Feb 24, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Lichter JayDirector | Sale | −324.7K | $2.98 | $967K | 984.7Kindirect | Feb 24, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Lichter JayDirector | Sale | −95.1K | $2.89 | $275K | 719.9Kindirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Lichter JayDirector | Sale | −173.0K | $2.89 | $500K | 1.3Mindirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| LOUMEAU ERIC JGC & Chief Compliance Officer | Sale | −1,206 | $18.75 | $23K | 0direct | Jun 26, 2017 | Jun 27, 2017 | Form 4 ↗ |
| LOUMEAU ERIC JGC & Chief Compliance Officer | Sale | −2,316 | $18.50 | $43K | 1,206direct | Jun 23, 2017 | Jun 27, 2017 | Form 4 ↗ |
| LeBel CarlChief Scientific Officer | Sale | −1,456 | $18.07 | $26K | 9,458direct | Nov 21, 2016 | Nov 22, 2016 | Form 4 ↗ |
| LeBel CarlChief Scientific Officer | Sale | −9,169 | $18.07 | $166K | 9,458direct | Nov 18, 2016 | Nov 22, 2016 | Form 4 ↗ |
| LeBel CarlChief Scientific Officer | Sale | −5,304 | $17.95 | $95K | 9,458direct | Sep 6, 2016 | Sep 8, 2016 | Form 4 ↗ |
| LeBel CarlChief Scientific Officer | Sale | −3,813 | $17.95 | $68K | 14.8Kdirect | Sep 6, 2016 | Sep 8, 2016 | Form 4 ↗ |
| LeBel CarlChief Scientific Officer | Sale | −12.1K | $17.95 | $218K | 18.6Kdirect | Sep 6, 2016 | Sep 8, 2016 | Form 4 ↗ |
| LeBel CarlChief Scientific Officer | Sale | −8,061 | $28.38 | $229K | 8,920direct | Dec 21, 2015 | Dec 22, 2015 | Form 4 ↗ |
| LeBel CarlChief Scientific Officer | Sale | −13.2K | $27.83 | $367K | 17.0Kdirect | Dec 21, 2015 | Dec 22, 2015 | Form 4 ↗ |
| Cayer Paul ECh. Financial & Business Offcr | Sale | −300 | $30.19 | $9K | 9,610direct | Dec 17, 2015 | Dec 18, 2015 | Form 4 ↗ |
| Cayer Paul ECh. Financial & Business Offcr | Sale | −2,700 | $29.65 | $80K | 9,910direct | Dec 17, 2015 | Dec 18, 2015 | Form 4 ↗ |
| Weber David AllenPresident & CEO · Director | Sale | −5,208 | $27.25 | $142K | 17.6Kdirect | Dec 15, 2015 | Dec 16, 2015 | Form 4 ↗ |
| Savel Robert Michael IIChief Technical Officer | Sale | −100 | $27.70 | $3K | 1,256direct | Dec 14, 2015 | Dec 16, 2015 | Form 4 ↗ |
| Savel Robert Michael IIChief Technical Officer | Sale | −1,289 | $27.26 | $35K | 1,356direct | Dec 14, 2015 | Dec 16, 2015 | Form 4 ↗ |
| Savel Robert Michael IIChief Technical Officer | Sale | −1,289 | $26.15 | $34K | 2,645direct | Dec 14, 2015 | Dec 16, 2015 | Form 4 ↗ |
| Savel Robert Michael IIChief Technical Officer | Sale | −2,322 | $25.14 | $58K | 3,934direct | Dec 14, 2015 | Dec 16, 2015 | Form 4 ↗ |
| ORBIMED ADVISORS LLCDirector | Sale | −590 | $29.22 | $17K | 1.9Mindirect | Nov 30, 2015 | Nov 30, 2015 | Form 4 ↗ |
| ORBIMED ADVISORS LLCDirector | Sale | −2,716 | $28.64 | $78K | 1.9Mindirect | Nov 30, 2015 | Nov 30, 2015 | Form 4 ↗ |
| Khuong Chau QuangDirector | Sale | −590 | $29.22 | $17K | 1.9Mindirect | Nov 30, 2015 | Nov 30, 2015 | Form 4 ↗ |
| Khuong Chau QuangDirector | Sale | −2,716 | $28.64 | $78K | 1.9Mindirect | Nov 30, 2015 | Nov 30, 2015 | Form 4 ↗ |
| ORBIMED ADVISORS LLCDirector | Sale | −29.0K | $28.97 | $840K | 1.9Mindirect | Nov 27, 2015 | Nov 30, 2015 | Form 4 ↗ |
| Khuong Chau QuangDirector | Sale | −29.0K | $28.97 | $840K | 1.9Mindirect | Nov 27, 2015 | Nov 30, 2015 | Form 4 ↗ |
| ORBIMED ADVISORS LLCDirector | Sale | −34.8K | $28.91 | $1.0M | 1.9Mindirect | Nov 25, 2015 | Nov 30, 2015 | Form 4 ↗ |
| Khuong Chau QuangDirector | Sale | −34.8K | $28.91 | $1.0M | 1.9Mindirect | Nov 25, 2015 | Nov 30, 2015 | Form 4 ↗ |
| Khuong Chau QuangDirector | Sale | −36.1K | $28.75 | $1.0M | 1.9Mindirect | Nov 24, 2015 | Nov 24, 2015 | Form 4 ↗ |
| OrbiMed Capital GP IV LLCDirector | Sale | −36.1K | $28.75 | $1.0M | 1.9Mindirect | Nov 24, 2015 | Nov 24, 2015 | Form 4 ↗ |
| Khuong Chau QuangDirector | Sale | −80.8K | $28.45 | $2.3M | 2.0Mindirect | Nov 23, 2015 | Nov 24, 2015 | Form 4 ↗ |
| OrbiMed Capital GP IV LLCDirector | Sale | −80.8K | $28.45 | $2.3M | 2.0Mindirect | Nov 23, 2015 | Nov 24, 2015 | Form 4 ↗ |
| Khuong Chau QuangDirector | Sale | −83.9K | $28.59 | $2.4M | 2.0Mindirect | Nov 20, 2015 | Nov 24, 2015 | Form 4 ↗ |
| OrbiMed Capital GP IV LLCDirector | Sale | −83.9K | $28.59 | $2.4M | 2.0Mindirect | Nov 20, 2015 | Nov 24, 2015 | Form 4 ↗ |
| OrbiMed Capital GP IV LLCDirector | Sale | −127.3K | $28.60 | $3.6M | 2.1Mindirect | Nov 19, 2015 | Nov 19, 2015 | Form 4 ↗ |
| Khuong Chau QuangDirector | Sale | −127.3K | $28.60 | $3.6M | 2.1Mindirect | Nov 19, 2015 | Nov 19, 2015 | Form 4 ↗ |
| OrbiMed Capital GP IV LLCDirector | Sale | −200 | $29.09 | $6K | 2.2Mindirect | Nov 17, 2015 | Nov 19, 2015 | Form 4 ↗ |
| OrbiMed Capital GP IV LLCDirector | Sale | −10.9K | $28.80 | $314K | 2.2Mindirect | Nov 17, 2015 | Nov 19, 2015 | Form 4 ↗ |
| Khuong Chau QuangDirector | Sale | −200 | $29.09 | $6K | 2.2Mindirect | Nov 17, 2015 | Nov 19, 2015 | Form 4 ↗ |
| Khuong Chau QuangDirector | Sale | −10.9K | $28.80 | $314K | 2.2Mindirect | Nov 17, 2015 | Nov 19, 2015 | Form 4 ↗ |
| Cayer Paul ECh. Financial & Business Offcr | Sale | −3,000 | $28.69 | $86K | 9,610direct | Nov 17, 2015 | Nov 17, 2015 | Form 4 ↗ |
| Weber David AllenPresident & CEO · Director | Sale | −100 | $29.25 | $3K | 17.6Kdirect | Nov 16, 2015 | Nov 17, 2015 | Form 4 ↗ |
| Weber David AllenPresident & CEO · Director | Sale | −5,108 | $28.56 | $146K | 17.7Kdirect | Nov 16, 2015 | Nov 17, 2015 | Form 4 ↗ |
| Weber David AllenPresident & CEO · Director | Sale | −10.4K | $30.95 | $322K | 539direct | Nov 13, 2015 | Nov 13, 2015 | Form 4 ↗ |
| Cayer Paul ECFO/Ch. Business Offcr & Sec. | Sale | −3,000 | $24.95 | $75K | 9,610direct | Nov 11, 2015 | Nov 12, 2015 | Form 4 ↗ |
| Weber David AllenPresident & CEO · Director | Sale | −5,208 | $24.95 | $130K | 539direct | Nov 11, 2015 | Nov 12, 2015 | Form 4 ↗ |
| LeBel CarlChief Scientific Officer | Sale | −21.3K | $24.36 | $518K | 8,920direct | Sep 21, 2015 | Sep 22, 2015 | Form 4 ↗ |
| Cayer Paul ECFO/Ch. Business Offcr & Sec. | Sale | −3,000 | $24.95 | $75K | 9,610direct | Sep 17, 2015 | Sep 18, 2015 | Form 4 ↗ |
| Weber David AllenPresident & CEO · Director | Sale | −5,216 | $24.95 | $130K | 539direct | Sep 15, 2015 | Sep 16, 2015 | Form 4 ↗ |
| Savel Robert Michael IIChief Technical Officer | Sale | −5,000 | $23.98 | $120K | 1,256direct | Sep 14, 2015 | Sep 15, 2015 | Form 4 ↗ |
| Savel Robert Michael IIChief Technical Officer | Sale | −25.0K | $23.73 | $593K | 1,256direct | Jun 15, 2015 | Jun 17, 2015 | Form 4 ↗ |
| CAPPS VICKIE LDirector | Purchase | +1,600 | $24.35 | $39K | 1,600indirect | May 22, 2015 | May 27, 2015 | Form 4 ↗ |
| CAPPS VICKIE LDirector | Purchase | +3,400 | $24.36 | $83K | 3,400direct | May 22, 2015 | May 27, 2015 | Form 4 ↗ |
| Novo A/S10% owner | Purchase | +15.7K | $15.50 | $243K | 2.2Mdirect | Aug 19, 2014 | Aug 21, 2014 | Form 4 ↗ |
| MCKEARN JOHN PDirector | Sale | −5,340 | n/c | — | 215.7Kindirect | Aug 18, 2014 | Aug 19, 2014 | Form 4 ↗ |
| MCKEARN JOHN PDirector | Sale | −19.7K | n/c | — | 794.2Kindirect | Aug 18, 2014 | Aug 19, 2014 | Form 4 ↗ |
| Avalon Ventures X, L.P.10% owner | Purchase | +109.4K | $16.00 | $1.8M | 815.0Kindirect | Aug 18, 2014 | Aug 19, 2014 | Form 4 ↗ |
| Avalon Ventures X, L.P.10% owner | Sale | −50.0K | $16.00 | $800K | 1.5Mdirect | Aug 18, 2014 | Aug 19, 2014 | Form 4 ↗ |
| OrbiMed Capital GP IV LLC10% owner | Purchase | +171.9K | $16.00 | $2.8M | 2.3Mindirect | Aug 18, 2014 | Aug 19, 2014 | Form 4 ↗ |
| Khuong Chau QuangDirector · 10% owner | Purchase | +171.9K | $16.00 | $2.8M | 2.3Mindirect | Aug 18, 2014 | Aug 19, 2014 | Form 4 ↗ |
| Lichter JayDirector · 10% owner | Purchase | +109.4K | $16.00 | $1.8M | 815.0Kindirect | Aug 18, 2014 | Aug 19, 2014 | Form 4 ↗ |
| Lichter JayDirector · 10% owner | Sale | −50.0K | $16.00 | $800K | 1.5Mindirect | Aug 18, 2014 | Aug 19, 2014 | Form 4 ↗ |
| Novo A/S10% owner | Purchase | +171.9K | $16.00 | $2.8M | 2.2Mdirect | Aug 18, 2014 | Aug 19, 2014 | Form 4 ↗ |
| BONDERMAN DAVID10% owner | Purchase | +171.9K | — | — | 2.2Mindirect | Aug 18, 2014 | Aug 19, 2014 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →